Active Ingredient History
Valganciclovir, sold under the brand name Valcyte among others, is an antiviral medication used to treat cytomegalovirus (CMV) infection in those with HIV/AIDS or following organ transplant. It is often used long term as it only suppresses rather than cures the infection. Valganciclovir is taken by mouth. Wikipedia
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Cytomegalovirus (approved 2001)
Bone Marrow Transplantation (Phase 3)
Burkitt Lymphoma (Phase 2)
Castleman Disease (Phase 4)
Colitis, Ulcerative (Phase 3)
Critical Illness (Phase 2)
Cytomegalovirus (Phase 3)
Cytomegalovirus Infections (Phase 4)
Cytomegalovirus Retinitis (Phase 3)
Depressive Disorder, Major (Phase 1/Phase 2)
Epstein-Barr Virus Infections (Phase 2)
Fatigue Syndrome, Chronic (Phase 1/Phase 2)
Glioblastoma (Phase 2)
Head and Neck Neoplasms (Phase 2)
Healthy Volunteers (Phase 1)
Hearing Loss, Sensorineural (Phase 3)
Heart Transplantation (Phase 4)
Hematopoietic Stem Cell Transplantation (Phase 3)
Herpesvirus 8, Human (Phase 2)
HIV (Phase 2)
HIV Infections (Phase 4)
Hodgkin Disease (Phase 2)
Idiopathic Pulmonary Fibrosis (Phase 1)
Infections (Phase 3)
Inflammatory Bowel Diseases (Phase 3)
Kidney Diseases (Phase 4)
Kidney Transplantation (Phase 4)
Leukemia (Phase 2)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 4)
Livedoid Vasculopathy (Phase 3)
Liver Transplantation (Phase 4)
Lung Transplantation (Phase 2)
Lymphoid Tissue (Phase 2)
Lymphoma (Phase 2)
Lymphoma, Extranodal NK-T-Cell (Phase 2)
Lymphoma, Large-Cell, Immunoblastic (Phase 2)
Lymphoma, Non-Hodgkin (Phase 3)
Lymphoproliferative Disorders (Phase 2)
Nasopharyngeal Carcinoma (Phase 1)
Neoplasms (Phase 2)
Organ Transplantation (Phase 4)
Pneumonia (Phase 2/Phase 3)
Sarcoma, Kaposi (Phase 2)
Stomach Neoplasms (Phase 2)
Transplantation (Phase 3)
Tuberculosis (Phase 2/Phase 3)
Uveitis (Phase 2/Phase 3)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
